Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

El.En.

Investor Presentation • Sep 29, 2017

4393_cp_2017-09-29_46c6055a-2d7a-4db7-a658-81830a10d736.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

COMPANY PRESENTATION

We Laser your World

ITALIAN CONFERENCE 2017, JPMORGAN Sept. 29th , 2017

DISCLAIMER

Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-lookingstatements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.

AGENDA

The El.En. Group

The El.En. Group

A Primary Player Providing Medical, Industrial, and Conservation Laser Solutions Worldwide

Hi-Tech company

International Group

Hi-Tech industrial group active in opto-electronics with proprietary technologies and knowhow developed over 35 years

More than 20 companies active worldwide on several markets and application segments. Listed on the Milan Stock Exchange, Star segment

Among the leaders in the global market

Worldwide distribution network

Progressively widening its worldwide presence registered continuous growth over the years

1,100 employees worldwide, more than 40,000 laser sources sold

Constant Growth

13% Revenue CAGR 2011 – 2016

40% EBIT CAGR 2011 – 2016

FY 2016 Consolidated Revenue at €253m, up 16% YoY, H1 2017 €143m up 19%

5

El.En. Worldwide

OurStrenghts

  • Dynamic R&D activity performed in several centers of excellence
  • Exploiting 35 years of know how
  • Competition through incremental and breakthrough innovations
  • Worldwide presence through a wide network of distributors with direct distribution in selected countries
  • Multi brand approach to maximize penetration in medical markets

Our Markets

Medical& Aesth energy-based systems market

\$
l
l
U
S
i
i
m
o
n		 2
0
1
4		 2
0
1
6		 2
0
2
1		 C
A
G
R		 C
A
G
R
6
1
4-
1		 6-
2
1
1
l
b
l
l
l
i
i
d
i
i
G
o
a
n
o
n-
n
a
s
e
a
n
m
n
m
a
v
v
y
d
l
h
i
i
i
i
t
t
t
t
t
n
v
a
s
v
e
m
e
c
a
a
e
s
e
c
r
e
a
m
e
n
t
s
y
s
e
m
s		 6.
9
3
2		 8.
4
3
7		 1
3.
9
9
2		 1
0
%		 1
1
%
b
d
E
t
t
t
t
n
e
r
g
y
a
s
e
r
e
a
m
e
n
s
y
s
e
m
s
-		 2.
0
3
3		 2.
6
7
0		 4.
3
8
0		 1
5
%		 1
0
%
d
h
&
k
h
B
i
S
i
i
i
t
t
o
y
s
a
p
n
g
n
g
e
n
n
g		 7
2
4		 9
9
6		 1.
9
6
5		 1
7
%		 1
5
%
k
S
i
j
i
t
n
r
e
u
v
e
n
a
o
n		 5
2
3		 6
9
5		 1.
0
8
9		 1
5
%		 9
%
l
H
i
a
r
r
e
m
o
v
a		 3
5
3		 3
4
1		 3
3
3		 -2
%		 0
%
L
i
t
t
t
e
g
v
e
n
r
e
a
m
e
n
s		 1
3
1		 1
5
7		 1
8
7		 9
%		 4
%
d
i
A
t
c
n
e
r
e
c
o
n
u		 9
6		 1
1
0		 1
2
5		 %
7		 %
3
l
i
j
i
V
t
a
n
a
r
e
e
n
a
o
n
g
u
v		 n
a		 1
0
5		 3
3
2		 n
a		 %
2
6
d
l
&
l
P
i
i
t
t
t
t
g
m
e
n
e
e
s
o
n
a
o
o
r
e
m
o
v
a		 8
0		 9
9		 1
4
2		 %
1
1		 %
7
h
O
t
e
r		 1
2
6		 1
6
7		 2
0
7		 1
5
%		 4
%
l
T
t
o
a		 2.
0
3
3		 2.
6
7
0		 4.
3
8
0		 1
5
%		 1
0
%

Source: Medical Insight Report

Key growth drivers:

  • Increasingly aging population
  • Desire to achieve or maintain more youthful appearance
  • Increase in healthcare spending
  • Requirements for fast and minimally invasive surgical procedures

Industrial laser market

Lasers increasingly adopted in high quality manufacturing for uniqueness, flexibility, environment friendliness, productivity

  • •Sheet metal cutting: technology breakthroughs lead to strong widening of demand
  • •Laser marking for identification: traceability as a quality standard

Market forecast for high power laser systems: 2016-2020 CAGR 7,6%

Source: Optech Consulting

Growth drivers

Growthdrivers

  • Expected growth in our main markets: Aesthetic , Surgery, Industrial
  • Novel body contouring and cellulite treatment device
  • Novel dermatologic treatment device
  • Picosecond tattoo removal lasers: new wavelength and max peak power
  • Broaden indications of use for MonaLisa Touch through extensive clinicals
  • Diabetic foot ulcers: seeking regulatory clearances worldwide
  • >1 kW RF CO2laser source launched @ Laser 2017
  • Strong demand for high power laser sheet metal cutting systems in China and Europe

A pathof growth

  • Constant growth driven by strong execution and favorable market conditions
  • 2016 EBITDA margin 12,8% and EBIT margin 10,9%

Financial Highlights

Financials2016

&
l
L
i
i
i
P
M
F
D
t
a
n
n
a
n
a
a
a
c
-		 /
/
3
1
1
2
1
5		 % /
/
3
1
1
2
1
6		 % V
%
a
r.
R
e
v
e
n
u
e
s		 2
1
7
6
7
0		 %
1
0
0
0
,		 2
5
2
6
4
6		 %
1
0
0
0
,		 %
1
6
1
,
E
B
I
T
D
A		 2
6
6
6
5		 8
%
1
1,		 3
2
3
8
8		 2,
8
%
1		 2
6
2
%
,
E
B
I
T		 2
1
4
9
9		 9
9
%
,		 2
7
5
9
4		 1
0
9
%
,		 2
8
4
%
,
N
I
t
e
n
c
o
m
e		 1
4
3
7
1		 %
6
6
,		 4
0
4
0
8		 %
1
6,
0		 %
1
8
1,
2
R
e
v
e
n
u
e
s		 /
/
3
1
1
2
1
5		 % /
/
3
1
1
2
1
6		 % %
V
a
r.
d
l
i
M
e
c
a		 1
1
0
2
4
7		 6
6
%
7
,		 1
6
6
0
6
5		 6
%
5,
7		 1
2,
9
%
l
d
I
i
t
n
u
s
r
a		 7
0
5
6
8		 3
2,
4
%		 8
6
5
9
0		 3
4
3
%
,		 2
2,
7
%

IncomeStatement H1-2017

l
l
E
M
i
i
u
r
o
o
n		 /
/
3
0
0
6
2
0
1
6		 % /
/
3
0
0
6
2
0
1
7		 % %
V
a
r.
R 1
2
0
1
7
6		 1
0
0
0
%		 1
4
2
8
7
7		 1
0
0
0
%		 1
8
9
%
e
e
n
e
s
v
u
G
i
r
o
s
s
m
a
r
g
n		 3
2
6
4
5		 ,
4
4
3
%
,		 9
0
9
5
5		 ,
4
1,
%
7		 ,
1
1,
%
7
E
B
I
T
D
A		 6
1
5
5
7		 3
0
%
1
,		 6
9
1
5
4		 0
8
%
1
,		 0
6
%
-
,
E
B
I
T		 3
2
1
5
4		 3
%
1
1,		 3
3
1
1
4		 9
2
%
,		 2,
9
%
-
P
I
t
r
e
a
x
n
c
o
m
e		 3
5
9
7
9		 %
2
9
9
,		 1
0
8
8
1		 %
7
6
,		 %
6
9
8
-
,
i
N
t
e
n
c
o
m
e		 3
0
2
9
3		 %
2
5
2
,		 6
0
1
0		 %
4
2
,		 %
8
0
2
-
,
h
I
N
t
e
n
c
o
m
e
p
e
r
s
a
r
e		 1,
5
7		 0
3
1
,

Balance SheetH1-2017

l
l
E
M
i
i
u
r
o
o
n		 /
/
3
1
1
2
2
0
1
6		 /
/
3
0
0
6
2
0
1
7		 V
%
a
r.
l
T
t
t
t
o
a
n
o
n
c
u
r
r
e
n
a
s
s
e
s		 6
4
7
3
7		 6
4
5
6
2		 %
0
3
-
k
l
i
C
i
N
W
t
t
e
o
r
n
g
a
p
a		 6
0
5
4
1		 6
9
6
3
1		 ,
2
8
6
%
,
f
l
i
i
i
i
N
t
t
e
n
a
n
c
a
p
o
s
o
n		 8
2
8
4
7		 6
6
9
4
7		 1
9
3
%
-
,
l
b
l
L
i
i
i
i
t
t
o
n
g
e
r
m
a
e
s		 8
9
8
2		 8
8
5
6		 1,
4
%
-
N
E
i
t
t
e
q
u
y		 1
9
2
6
9
9		 1
9
2
1
3
1		 %
0
3
-
,
l
l
d
i
N
t
t
e
c
a
p
a
e
m
p
o
y
e		 0
9
9
1
1
5		 2
3
3
1
5
7		 0
%
1
4
,
k
l
l
i
C
i
N
W
t
t
e
o
r
n
g
a
p
a
o
n
s
a
e
s		 2
%
1		 2
%
4
O
C
R
E		 2
%
5		 2
1
%
/
(
)
l
l
d
I
i
E
B
T
N
t
t
e
c
a
p
a
e
m
p
o
y
e
C
a
p
e
x		 1
1
4
4
1		 1
6
3
6

H1 - Revenue breakdown

in Euro million

2017 Guidance

Multiples & Comparables

Multiples

k
h
l
d
's
i
h
S
E
t
t
o
c
o
e
r
q
p
e
r
s
a
r
e
u
y		 9
/
i
k
l
d
j.
P
B
V
A
r
c
e
o
o
a
u
e		 2,
6
/
(
)
8
0
%
E
V
E
B
I
T
E
B
I
T		 8,
1
5
/
l
(
l
)
S
8
0
%
S
E
V
a
e
s
a
e
s		 1,
7
l.
k
E
E
M
C
t
n.
a
r
e
a
p.		 6
8,
0
@
4		 2
2
€
4,
5
f
l
N
i
i
i
i
t
t
e
n
a
n
c
a
p
o
s
o
n		 6
6,
8
@		 /
/
3
0
0
6
2
0
1
7
/
i
i
l
i
l
F
t
t
t
n
a
n
a
n
e
s
m
e
n
s
m
e
r
m
c
v		 1
2,
0
@		 /
/
3
0
0
6
2
0
1
7

Comparables

/
d
l
he
ica
Ae
ic
Me
t
t
s		 Pr
ice		 Re
ve
nu
e		 %
Va
r.
Re
ve
nu
e		 E
B
I
T		 E
B
I
T
%		 M
K.
Ca
p.		 E
V		 /
les
E
V
Sa
(
*)		 /
E
V
E
B
I
(
*)
T		 h
Ca
s
/
d
A
j.
P
E
(
*)		 /
k
P
Bo
o
lue
Va
Cu
te
ra		 \$
3
9,
6
5		 \$
6
6
8
8
5.		 3
2
%		 \$
3
1
7		 0
%		 \$
3
0
0
5
5
5.		 \$
0
2.
0
6
5
1		 3,
8		 9
9
7
1,		 2
7
1,
4		 9,
2
io
las
B
e		 \$
0,
6
0		 \$
2
3.
8
6
4		 %
-5		 \$
(
)
8.
6
5
5		 -3
6
%		 \$
9
0
4
5.
5		 \$
3
2
3
7.
4		 0,
8		 n.a n.a 8
1,
du
ia
l
In
tr
s
ho
ics
I
P
G
P
Co
to
n		 \$
1
8
2,
0
8		 \$
6
5
5.
2
1
9		 %
4
2		 \$
2
4
2.
6
2
3		 %
3
7		 \$
9.
8
0
8.
0
0
0		 \$
8.
8
7
8.
7
7
3		 6,
8		 1
8,
3		 2
4,
8		 5,
4
im
du
ie
Pr
In
tr
a
s		 €
3
9,
3
5		 €
2
0
2.
4
1
5		 %
1
0		 €
1
0.
6
4
4		 %
5		 €
4
1
2.
5
2
0		 €
5
0
8.
0
1
0		 1,
3		 2
3,
9		 3
3,
8		 3,
0
l.
(
)
E
En
1		 €
2
4,
2
5		 €
1
4
2.
8
7
7		 1
9
%		 €
1
3.
1
3
4		 9
%		 €
4
6
7.
9
6
4		 €
3
8
9.
2
1
6		 1,
7		 1
8,
5		 3
2,
4		 2,
6
(
)
d m
l
ip
l
ies
1
E
V a
t
n
u
(
*)
b
d e
Re
E
i
t a
ve
nu
e,
n		 for
iou
as
p
rev
s s
ing
ar
n
s a
nn
ua		 l
i
de
l
d
ize

Contacts

El.En. SPA

Enrico ROMAGNOLI Investor Relations Managertel. +39 055-8826807E-mail: [email protected]

POLYTEMS HIR

Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI [email protected]@polytemshir.it ; [email protected] Tel. +39 06-69923324

More from El.En.

Regulatory Filings 2025
Dec 22
Transaction in Own Shares 2025
Dec 22
Share Issue/Capital Change 2025
Dec 22
Transaction in Own Shares 2025
Dec 3
Investor Presentation 2025
Dec 3
Report Publication Announcement 2025
Dec 3
Report Publication Announcement 2025
Dec 3
Registration Form 2025
Nov 28
Share Issue/Capital Change 2025
Nov 28
Share Issue/Capital Change 2025
Nov 28
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.